High Performance Digital NMR Spectrometer Console
高性能数字核磁共振波谱仪控制台
基本信息
- 批准号:7793710
- 负责人:
- 金额:$ 42.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyloidosisArtsBiomolecular Nuclear Magnetic ResonanceCommunicable DiseasesDiseaseElectronicsFundingFutureGenerationsHealthHumanInvestmentsMalignant NeoplasmsMinorMolecularMyotonic DystrophyNerve DegenerationPerformancePhasePhysiologic pulseRelaxationRequest for ProposalsResearchResearch InstituteSamplingUnited Statesbasecryogenicsdigitalimprovedinstrumentinstrumentationprogramsradiofrequencyresearch studystructural biology
项目摘要
DESCRIPTION (provided by applicant): The Biomolecular NMR facility at The Scripps Research Institute is one of the foremost in the United States. Scripps has made an extraordinary investment over the past two decades in building and equipping this facility but the electronics consoles on many of the spectrometers are now obsolete and need to be replaced. This proposal requests funding to replace the obsolete 1997-vintage DRX console on our most sensitive instrument, an 800 MHz spectrometer equipped with a cryogenic probe, with a state-of- the-art Avance III console. The new electronics console is expected to increase the sensitivity of the instrument by as much as 25%, provide enhanced radiofrequency generation and phase stability to improve the performance of demanding pulse experiments, and enable the implementation of new 2H relaxation and non-linear sampling experiments that simply cannot be performed with our existing instrumentation. The upgraded electronics will directly benefit the NIH-funded research programs of four major user groups (Dyson, Williamson, Wright, and W|thrich) and two minor users (Kelly and Otomo). These research programs are probing fundamental questions in structural biology and are addressing key issues related to human health and disease. The enhanced capabilities of the instrument will facilitate ongoing and future research on the underlying molecular basis of cancer, myotonic dystrophy, neurodegeneration, amyloid diseases, and infectious disease.
描述(由申请人提供):斯克里普斯研究所的生物分子核磁共振设施是美国最重要的设施之一。在过去的二十年里,斯克里普斯在建造和装备这一设施方面进行了巨大的投资,但许多光谱仪上的电子控制台现在已经过时,需要更换。这项提案要求提供资金,以取代我们最敏感的仪器上过时的1997年老式DRX控制台,这是一台配备低温探头的800 MHz光谱仪,使用最先进的Avance III控制台。新的电子控制台预计将增加仪器的灵敏度高达25%,提供增强的射频生成和相位稳定性,以提高要求苛刻的脉冲实验的性能,并使新的2H弛豫和非线性采样实验的实施,根本不能与我们现有的仪器进行。升级后的电子设备将直接使四个主要用户群体(戴森、威廉姆森、赖特和W| thrich)和两个小用户(Kelly和Otomo)。这些研究项目正在探索结构生物学的基本问题,并解决与人类健康和疾病相关的关键问题。该仪器的增强功能将促进对癌症、强直性肌营养不良、神经变性、淀粉样蛋白疾病和传染病的潜在分子基础的正在进行的和未来的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER Edwin WRIGHT其他文献
PETER Edwin WRIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER Edwin WRIGHT', 18)}}的其他基金
Structural characterization of large eukaryotic proteins containing both folded and disordered domains
含有折叠和无序结构域的大型真核蛋白质的结构表征
- 批准号:
10552345 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
- 批准号:
10115719 - 财政年份:2020
- 资助金额:
$ 42.43万 - 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
- 批准号:
10599188 - 财政年份:2020
- 资助金额:
$ 42.43万 - 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
- 批准号:
10372930 - 财政年份:2020
- 资助金额:
$ 42.43万 - 项目类别:
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300
CBP/p300 调节细胞应激反应途径的分子基础
- 批准号:
10436187 - 财政年份:2018
- 资助金额:
$ 42.43万 - 项目类别:
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300
CBP/p300 调节细胞应激反应途径的分子基础
- 批准号:
10172869 - 财政年份:2018
- 资助金额:
$ 42.43万 - 项目类别:
Structural basis for CBP/p300 transcriptional regulation
CBP/p300 转录调控的结构基础
- 批准号:
7909484 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Recognition of Regulatory and Pathogenic RNA by Muscleblind Zinc Fingers
肌盲锌指识别调节性和致病性 RNA
- 批准号:
7924930 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
International Conference on Magnetic Resonance in Biological Systems 2008
2008 年生物系统磁共振国际会议
- 批准号:
7483664 - 财政年份:2008
- 资助金额:
$ 42.43万 - 项目类别:
NMR STRUCTURAL STUDIES OF PRION PROTEINS WITH POINT MUTATIONS
点突变朊病毒蛋白的核磁共振结构研究
- 批准号:
7447340 - 财政年份:2007
- 资助金额:
$ 42.43万 - 项目类别:
相似海外基金
DETERMINANTS OF OUTCOME TO DISEASE-MODIFYING THERAPY FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY
转甲状腺素蛋白淀粉样变性心肌病疾病缓解治疗结果的决定因素
- 批准号:
495435 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
21st century disease, innovative radiation therapy for amyloidosis
21世纪疾病,淀粉样变性的创新放射疗法
- 批准号:
23K07095 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
芯片磷酸化刺激突变运甲状腺素蛋白的降解以减轻心脏淀粉样变性
- 批准号:
10905158 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Development of a method to differentiate types of cardiac amyloidosis using Raman spectroscopy.
开发一种使用拉曼光谱区分心脏淀粉样变性类型的方法。
- 批准号:
23K17233 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New Developments in Amyloidosis Research Using Cordyceps Lectin
利用冬虫夏草凝集素研究淀粉样变性的新进展
- 批准号:
23K10950 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulatory mechanism of amyloidosis-like function of seminal vesicle secretory proteins in the acquisition of sperm capacitaion.
精囊分泌蛋白类淀粉样变性功能在精子获能过程中的调节机制。
- 批准号:
23K08748 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aortic Stenosis and Cardiac Amyloidosis
主动脉瓣狭窄和心脏淀粉样变性
- 批准号:
23K15548 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
腰椎管狭窄标本分析鉴定运甲状腺素蛋白心脏淀粉样变性
- 批准号:
10637491 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
The Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape.
淀粉样变性论坛:在不断发展的治疗格局中推进 ATTR 淀粉样变性的药物开发。
- 批准号:
10683562 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别: